The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(2-(Pyrrolidin-1-yl)acetyl)indolin-5-yl)thiophene-2-carboximidamide dihydrochloride ID: ALA3215676
PubChem CID: 71486267
Max Phase: Preclinical
Molecular Formula: C19H24Cl2N4OS
Molecular Weight: 354.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cl.Cl.N=C(Nc1ccc2c(c1)CCN2C(=O)CN1CCCC1)c1cccs1
Standard InChI: InChI=1S/C19H22N4OS.2ClH/c20-19(17-4-3-11-25-17)21-15-5-6-16-14(12-15)7-10-23(16)18(24)13-22-8-1-2-9-22;;/h3-6,11-12H,1-2,7-10,13H2,(H2,20,21);2*1H
Standard InChI Key: VVCPPABXTSCSTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
8.0553 -0.6207 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9300 3.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5905 3.5979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.0779 5.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5472 5.5187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2884 4.2146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2772 3.1068 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6552 -2.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1277 -4.3539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3877 -3.5218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5493 -4.7909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5553 -6.2909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1306 -6.7602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2441 -5.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5553 -0.6207 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 6 1 0
2 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 13 1 0
8 19 1 0
19 20 1 0
20 21 1 0
19 22 2 0
21 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.48Molecular Weight (Monoisotopic): 354.1514AlogP: 3.17#Rotatable Bonds: 4Polar Surface Area: 59.43Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.65CX LogP: 2.43CX LogD: 1.97Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: -2.10
References 1. Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F.. (2012) Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine., 55 [PMID:22840695 ] [10.1016/j.ejmech.2012.07.006 ]